Skip to main content

Table 1 Baseline characteristics of the study patients

From: Clinical outcomes after pulmonary vein isolation using an automated tagging module in patients with paroxysmal atrial fibrillation

 

Overall

(N = 157)

VISITAG (-)

(N = 95)

VISITAG (+)

(N = 62)

P value

Age

56.7 ± 10.9

55.6 ± 11.2

58.5 ± 10.2

0.099

Men

115 (73.2)

70 (73.7)

45 (72.6)

> 0.99

BMI

24.6 ± 3.4

24.8 ± 3.1

24.3 ± 3.8

0.339

Previous medical history

Hypertension

51 (32.5)

32 (33.7)

19 (30.6)

0.823

Diabetes

14 (8.9)

8 (8.4)

6 (9.7)

> 0.99

Congestive heart failure

3 (1.9)

2 (2.1)

1 (1.6)

> 0.99

Vascular disease

4 (2.5)

3 (3.2)

1 (1.6)

0.934

Ischemic stroke/TIA

16 (10.2)

6 (6.3)

10 (16.1)

0.086

CHA2DS2-VASc score

1.2 ± 1.4

1.1 ± 1.4

1.4 ± 1.3

0.284

CHA2DS2-VASc score ≥ 2

54 (34.4)

28 (29.5)

26 (41.9)

0.151

Left ventricular ejection fraction, %

61.0 ± 6.3

61.0 ± 6.1

60.9 ± 6.7

0.905

Left atrial size, mm

39.6 ± 5.5

39.4 ± 4.9

39.9 ± 6.3

0.554

Left atrial volume, ml

112.5 ± 32.9

116.6 ± 31.8

108.0 ± 33.8

0.147

Amiodarone

14 (8.9)

8 (8.4)

6 (9.7)

>0.99

Class 1C drug

120 (76.4)

68 (71.6)

52 (83.9)

0.114

Beta-blocker

47 (29.9)

22 (23.2)

25 (40.3)

0.034

Calcium channel blockers

47 (29.9)

32 (33.7)

15 (24.2)

0.275

Digoxin

10 (6.4)

2 (2.1)

8 (12.9)

0.018

  1. BMI body mass index; TIA transient ischemic attack
  2. Data are presented as mean ± standard deviation or number (%)